Rationale and design of the BAYES (Interatrial Block and Yearly Events) registry

Manuel Martínez-Sellés1, Adrian Baranchuk2, Roberto Elosua3

  • 1Department of Cardiology, Hospital General Universitario Gregorio Marañón, Universidad Europea, Universidad Complutense, Madrid, Spain.

Clinical Cardiology
|November 25, 2016
PubMed

Insights

Interatrial block (IAB) is common in elderly heart patients and linked to higher risks. This study tracks IAB

Area of Science:

  • Cardiology
  • Geriatrics
  • Electrophysiology

Background:

  • Interatrial block (IAB) is prevalent in elderly individuals with heart disease.
  • IAB is associated with increased risks of atrial fibrillation (AF), stroke, and cognitive decline.
  • Limited data exists on the long-term prognosis of IAB in older adults.

Purpose of the Study:

  • To evaluate the impact of interatrial block (IAB) on the risk of atrial fibrillation (AF) and stroke.
  • To assess the 3-year prognosis of elderly patients with heart disease and varying degrees of IAB.
  • To inform potential therapeutic strategies, such as anticoagulation, for elderly patients with IAB.

Main Methods:

  • The Interatrial Block and Yearly Events (BAYES) registry enrolled 654 ambulatory patients aged ≥70 years with heart disease.
  • Patients were categorized into three groups based on P-wave duration and morphology: normal, partial IAB, and advanced IAB.
  • Primary endpoints included documented AF (>5 minutes) and stroke over a 3-year follow-up period.

Main Results:

  • Results are pending, but the study aims to clarify the prognostic significance of IAB in elderly cardiac patients.
  • The study will provide crucial data on the incidence of AF and stroke in relation to IAB severity.
  • Findings are expected to enhance understanding of IAB's role in cardiovascular outcomes for older adults.

Conclusions:

  • This registry will elucidate the clinical significance of interatrial block (IAB) in elderly patients with heart disease.
  • The study outcomes may guide the management of AF and stroke risk in this vulnerable population.
  • Results could support the consideration of anticoagulation therapy for specific elderly patients identified with IAB.